{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:54:15Z","timestamp":1761897255123},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1245\/s10434-020-08308-w","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T18:06:22Z","timestamp":1583863582000},"page":"2525-2536","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection of Mesenteric Tumor Using Dynamic Contrast Enhanced MRI"],"prefix":"10.1245","volume":"27","author":[{"given":"Russell N.","family":"Low","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridgette","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Bahador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jula","family":"Veerapong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"8308_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1245\/s10434-015-5005-2","volume":"23","author":"K Mohkam","year":"2016","unstructured":"Mohkam K, Passot G, Cotte E, et al. Resectability of peritoneal carcinomatosis: learnings from a prospective cohort of 533 consecutive patients selected for cytoreductive surgery. Ann Surg Oncol. 2016:23:1261\u201370.","journal-title":"Ann Surg Oncol."},{"key":"8308_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/1477-7819-12-332","volume":"12","author":"E Marcotte","year":"2014","unstructured":"Marcotte E, Dub\u00e9 P, Drolet P, et al. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis. World J Surg Oncol. 2014;12:332. https:\/\/doi.org\/10.1186\/1477-7819-12-332.","journal-title":"World J Surg Oncol."},{"key":"8308_CR3","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1245\/s10434-014-4148-x","volume":"22","author":"TR van Oudheusden","year":"2015","unstructured":"van Oudheusden TR, Braam HJ, Luyer MDP, Wiezer MJ, van Ramshorst B, Nienhuijs SW, de Hingh IHJT. Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis. Ann Surg Oncol. 2015;22:1236\u201342.","journal-title":"Ann Surg Oncol."},{"key":"8308_CR4","first-page":"244","volume":"20","author":"J Spiliotis","year":"2015","unstructured":"Spiliotis J, Halkia E, Rogdakis A, Kastrinaki K, Lianos E, Esftathiou E. Clinical history of patients with peritoneal carcinomatosis excluded from cytoreductive surgery & HIPEC. J BUON. 2015;20:244\u20137.","journal-title":"J BUON."},{"key":"8308_CR5","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2214\/AJR.07.2018","volume":"190","author":"RN Low","year":"2008","unstructured":"Low RN, Barone W, Gurney J, Muller W. Preoperative MR imaging of mucinous appendiceal neoplasm. Am J Roentgenol. 2008;190:656\u201365.","journal-title":"Am J Roentgenol."},{"key":"8308_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00330-002-1712-8","volume":"13","author":"J Ricke","year":"2003","unstructured":"Ricke J, Sehouli J, Hach C, Lopen Hanninen E, Lichtenegger W, Felix R. Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol. 2003;13:943\u20139.","journal-title":"Eur Radiol."},{"key":"8308_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","volume":"16","author":"JL Koh","year":"2009","unstructured":"Koh JL, Yan TD, Glenn D, Morris DL. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2009;16:327\u201333.","journal-title":"Ann Surg Oncol."},{"key":"8308_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1245\/s10434-012-2788-2","volume":"20","author":"RN Low","year":"2013","unstructured":"Low RN, Barone RM, Lee MJ. Surveillance MR Imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC. Ann Surg Oncol. 2013;20:1074\u201381.","journal-title":"Ann Surg Oncol."},{"key":"8308_CR9","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1245\/s10434-010-1492-3","volume":"18","author":"TC Chua","year":"2011","unstructured":"Chua TC, Al-Zahrani A, Saxena A, et al. Determining the association between preoperative computed tomography findings and post-operative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2011;18:1582\u20139.","journal-title":"Ann Surg Oncol."},{"key":"8308_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1102\/1470-7330.2011.0016","volume":"11","author":"CM Patel","year":"2011","unstructured":"Patel CM, Sahdev A, Reznek RH. CT, MRI, and PET imaging in peritoneal malignancy. Cancer Imaging. 2011;11:123\u201339.","journal-title":"Cancer Imaging."},{"key":"8308_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/mrm.22291","volume":"63","author":"AN Priest","year":"2010","unstructured":"Priest AN, Gill AB, Kataoka M, et al. Dynamic contrast-enhanced MRI in ovarian cancer: initial experience at 3 tesla in primary and metastatic disease. Magn Reson Med. 2010;63:1044\u20139. https:\/\/doi.org\/10.1002\/mrm.22291. [Pubmed].","journal-title":"Magn Reson Med."},{"key":"8308_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/mrm.22067","volume":"62","author":"MA McLean","year":"2009","unstructured":"McLean MA, Priest AN, Joubert I, et al. Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T. Magn Reson Med. 2009;62:855\u201361. https:\/\/doi.org\/10.1002\/mrm.22067. [Pubmed].","journal-title":"Magn Reson Med."},{"key":"8308_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/s00261-011-9825-7","volume":"37","author":"BD Klumpp","year":"2012","unstructured":"Klumpp BD, Aschoff P, Schwenzer N, et al. Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings. Abdom Radiol. 2012;37:834\u201342.","journal-title":"Abdom Radiol."},{"key":"8308_CR14","first-page":"2363","volume":"34","author":"EM Pasqual","year":"2014","unstructured":"Pasqual EM, Bertozzi S, Bacchetti S, et al. Perioperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic interperitoneal chemotherapy following cytoreductive surgery. Anti-cancer Res. 2014:34: 2363\u20138.","journal-title":"Anti-cancer Res."},{"key":"8308_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00261-007-9211-7","volume":"33","author":"C Dromain","year":"2008","unstructured":"Dromain C, Leboulleux S, Auperin A, et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET\/CT. Abdom Imag. 2008;33:87\u201393.","journal-title":"PET\/CT. Abdom Imag."},{"key":"8308_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2214\/AJR.08.1753","volume":"193","author":"RN Low","year":"2009","unstructured":"Low RN, Sebrechts C, Barone RM, Muller WD. Diffusion weighted MR imaging of peritoneal tumor: comparison with conventional and surgical and histopathologic findings: a feasibility study. An J Roentgenol. 2009;193:461\u201370.","journal-title":"An J Roentgenol."},{"key":"8308_CR17","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","volume":"22","author":"RN Low","year":"2015","unstructured":"Low, RN, Barone RM, Lucero J. Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2015;22:1708\u201315.","journal-title":"Ann Surg Oncol."},{"key":"8308_CR18","first-page":"1394","volume":"19","author":"RN Low","year":"2012","unstructured":"Low RN, Barone RM. Combined diffusion-weighted and gadolinium-enhanced MR imaging can accurately predict the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. J Surg Oncol. 2012;19:1394\u2013401.","journal-title":"J Surg Oncol."},{"key":"8308_CR19","doi-asserted-by":"publisher","unstructured":"van \u2018t Sant I, van Eden WJ, Engbersen MP, Kok NFM, Woensdregt K, Lambregts DMJ, Shanmuganathan S, Beets-Tan RGH, Aalbers AGJ, Lahaye MJ. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery. Br J Surg. 2018. https:\/\/doi.org\/10.1002\/bjs.10989.","DOI":"10.1002\/bjs.10989"},{"key":"8308_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejrad.2010.06.004","volume":"80","author":"M Bozkurt","year":"2011","unstructured":"Bozkurt M, Doganay S, Kantarci M, et al. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values. Eur J Radiol. 2011;80;224\u20138.","journal-title":"Eur J Radiol."},{"key":"8308_CR21","first-page":"313","volume":"363","author":"PS Tofts","year":"1991","unstructured":"Tofts PS, Wicks DA, Barker GJ. The MRI measurement of NMR and physiological parameters in tissue to study disease process. Prog Clin Biol Res. 1991; 363:313\u201325.","journal-title":"Prog Clin Biol Res."},{"key":"8308_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","volume":"10","author":"PS Tofts","year":"1999","unstructured":"Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imag. 1999;10:223\u201332.","journal-title":"J Magn Reson Imag."},{"key":"8308_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00002142-200108000-00006","volume":"12","author":"MV Knopp","year":"2001","unstructured":"Knopp MV, Giesel FL, Marcos H, von Tengg- Kobligk H, Choyke P. Dynamic contrast-enhanced magnetic resonance imaging in oncology. Top Magn Reson Imag. 2001;12:301\u20138.","journal-title":"Top Magn Reson Imag."},{"key":"8308_CR24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ygyno.2012.06.002","volume":"126","author":"DM Chase","year":"2012","unstructured":"Chase DM, Sill MW, Monk BJ, et al. Changes in tumor blood flow as measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) may predict activity of single agent bevacizumab in recurrent epithelial ovarian (EOC) and primary peritoneal cancer (PPC) patients: an exploratory analysis of a Gynecologic Oncology Group Phase II study. Gynecol Oncol. 2012;126:375\u201380.","journal-title":"Gynecol Oncol."},{"key":"8308_CR25","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2214\/AJR.12.8510","volume":"198","author":"S Verma","year":"2012","unstructured":"Verma S, Turkbey B, Muradya N, et al. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. Am J Roentgenol 2012;198:1277\u201388.","journal-title":"Am J Roentgenol"},{"key":"8308_CR26","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2214\/AJR.10.6356","volume":"197","author":"RN Low","year":"2011","unstructured":"Low RN, Fuller DB, Muradyan N. Dynamic gadolinium-enhanced perfusion MRI of prostate cancer: assessment of response to hypofractionated robotic stereotactic body radiation therapy. Am J Roentgenol. 2011;197:907\u201315.","journal-title":"Am J Roentgenol."},{"key":"8308_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2214\/AJR.09.2483","volume":"193","author":"RH El Khouli","year":"2009","unstructured":"El Khouli RH, Macura KJ, Jabobs MA, et al. Dynamic contrast-enhance MRI of the breast: Quantitative method for kinetic curve type assessment. Am J Roentgenol. 2009;193:295\u2013300.","journal-title":"Am J Roentgenol."},{"key":"8308_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1148\/radiol.2481071120","volume":"248","author":"I Thomassin-Naggara","year":"2008","unstructured":"Thomassin-Naggara I, et al. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology. 2008;248:148\u201359.","journal-title":"Radiology"},{"key":"8308_CR29","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ijrobp.2008.08.023","volume":"74","author":"MA Zahra","year":"2009","unstructured":"Zahra, M. A. et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys. 2009;74:766\u201373.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"4","key":"8308_CR30","doi-asserted-by":"publisher","first-page":"20190018","DOI":"10.1515\/pp-2019-0018","volume":"4","author":"J Spiliotis","year":"2019","unstructured":"Spiliotis J, Kalles V, Kyriazanos I, et al. CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: the small-bowel PCI score as a predictor of survival. Pleura Peritoneum. 2019;4(4):20190018. https:\/\/doi.org\/10.1515\/pp-2019-0018. eCollection 2019 Dec 1.","journal-title":"Pleura Peritoneum."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-020-08308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:13:25Z","timestamp":1615335205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-020-08308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["8308"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08308-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"18 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}